Compared with cDDP treatment alone, cDDP followed by γδ/αβ T immunotherapies significantly inhibited tumor growth and prolonged mouse survival, especially when cells were loaded with tumor antigen (γδ/Mix‐load), which showed the best antitumor effect (Figure 6d,e). Here, MIXL1 is linked to neoplasm.